|
Sector Watch
Panacea Biotec Forays into Healthcare
Panacea Biotec, a research based pharma company, is now expanding its portfolio
by entering into the fast growing healthcare delivery sector. Panacea Biotec
aims at providing the best treatment facilities with state-of-the-art equipment
handled by skilled professionals. For delivering the same, the company has entered
into collaboration with Dr Umesh Gupta, MD, Umkal Group to set-up a multi super-specialty
hospital at Gurgaon.
Umkal group is presently running multi-specialty health care institutions at
Gurgaon and New Delhi with over 150 beds. The company has signed a shareholders'
agreement with the existing shareholders of UMI and has agreed to make an investment
towards its equity contribution. With Panacea Biotec's leadership in providing
innovative medical therapies, and Umkal's long-term experience in providing
specialised healthcare, this collaboration would be unique and one-of-its-kind.
The total project cost would be funded by a mix of debt and equity. The hospital
is proposed to be a 220 bed super-specialty Hospital. Rajesh Jain, Joint Managing
Director-Panacea Biotec emphasised, "Entering into private healthcare is
an integral part of our long-term strategy that would take us closer to our
vision of becoming a leading health management company. The potential market
for a corporate hospital will comprise of the very rich, consuming class and
a part of climbers which would be close to 25-30 per cent of the market. We
would also target medical tourism."
EH News Bureau
|